Literature DB >> 73083

Propranolol and prolactin.

H A Nasrallah, W J Freed, A Rogol, R J Wyatt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 73083     DOI： 10.1016/s0140-6736(77)91563-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

Review 2.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  The effect on plasma prolactin, growth hormone and luteinising hormone concentrations of single oral doses or propranolol and tolamolol in normal man.

Authors:  C A Saxton; J K Faulkner; G V Groom
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  The effect of chronic oxprenolol therapy on blood prolactin, growth hormone, renin and aldosterone levels.

Authors:  M J Lewis; A Wilton; G V Groom; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

5.  The effect of propranolol treatment in shizophrenia on CSF amine metabolites and prolactin.

Authors:  R H Belmaker; R P Ebstein; H Dasberg; A Levy; G Sedvall; H M Van Praag
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.